GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Avalon GloboCare
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its stock price represents a venture bet on the success of its scientific programs. The chart reflects high volatility associated with clinical trial news.
Share prices of companies in the market segment - Treatment
Avalon GloboCare is a biotech company focused on developing cell therapies, including CAR-T, and providing healthcare services. We categorize it as a "Treatment" company. The chart below shows how the market values companies with a hybrid business model in biotech.
Broad Market Index - GURU.Markets
Avalon GloboCare is a biotech company developing cell therapies and providing healthcare services. Its diversified approach makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how Avalon compares to it.
Change in the price of a company, segment, and market as a whole per day
ALBT - Daily change in the company's share price Avalon GloboCare
Avalon GloboCare Corp.'s daily price change reflects the high volatility inherent in cell therapy companies. This metric measures its sensitivity to news about clinical trials and the development of its technology platform.
Daily change in the price of a set of shares in a market segment - Treatment
Avalon GloboCare is a cell therapy company, meaning it experiences high volatility tied to scientific breakthroughs. The chart below shows the average daily risk for the biotech sector. It serves as a benchmark for assessing the performance of ALBT stock.
Daily change in the price of a broad market stock, index - GURU.Markets
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its shares are a bet on scientific revolution. Their high volatility, driven by research, is part of the dynamic nature of the innovation sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Avalon GloboCare
Avalon GloboCare Corp.'s year-over-year performance tells the story of its diversified healthcare strategy. Its market capitalization over the past 12 months reflects both the performance of its network of medical centers and, more importantly, the progress of its cell therapy development programs, its primary bet for the future.
Annual dynamics of market capitalization of the market segment - Treatment
As an early-stage biotech, Avalon is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about the clinical trials of its cell therapy. Its stock price will reflect investors' speculative belief in the potential of its developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Avalon GloboCare is a biotech company whose fate is decided in the clinic, not on the stock market. Its year-over-year performance compared to the S&P 500 tells a story not about economics but about investors' faith in the success of its cell therapy. Any news of progress or setback can send the stock plummeting or plummeting.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Avalon GloboCare
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its monthly performance is driven by progress in its clinical programs and the success of its consulting business for other biotech companies.
Monthly dynamics of market capitalization of the market segment - Treatment
Avalon GloboCare Corp. is a biotechnology company focused on developing cell therapies, including CAR-T technologies, and managing the healthcare ecosystem. Its sector dynamics, shown in the chart, reflect the risks of R&D. Against this backdrop, it is possible to assess the development of its diversified strategy, combining cutting-edge developments with practical medical services.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Avalon GloboCare is a biotech company focused on cell therapy. Its shares are teetering on the edge of anticipation of clinical trial results. Their monthly performance is completely disconnected from the broader market, as the chart clearly illustrates, reflecting a reaction to scientific data rather than general economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Avalon GloboCare
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. Its weekly stock price is volatile and depends on progress in its clinical and preclinical programs.
Weekly dynamics of market capitalization of the market segment - Treatment
Avalon GloboCare operates in cell therapy and regenerative medicine. The chart clearly demonstrates whether the sharp weekly stock price movements are the result of unique company news about research progress or reflect general optimism or pessimism in the biotech sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Avalon GloboCare is a biotech company whose stock moves in sync with clinical trial news. This chart is a great way to see how its weekly fluctuations are disconnected from overall market trends. Is the company living its own life, or is it being affected by the global sell-off?
Market capitalization of the company, segment and market as a whole
ALBT - Market capitalization of the company Avalon GloboCare
The Avalon GloboCare chart shows a diversified position in biotech and healthcare. Its market capitalization reflects how the market values the company's complex portfolio, which includes cell therapy developments and healthcare consulting services.
ALBT - Share of the company's market capitalization Avalon GloboCare within the market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its market capitalization in the wellness and treatment segment reflects its broad range of interests, from developing CAR-T therapy to building a rehabilitation ecosystem. The company's market capitalization is a combined assessment of the potential of its various ambitious projects.
Market capitalization of the market segment - Treatment
Avalon GloboCare operates in the cell therapy field. How big is this arena? The chart below shows the overall market capitalization of the treatment sector. Its growth reflects the enormous potential of regenerative medicine and how investors value the companies at the forefront of this revolution.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Avalon GloboCare chart shows how the market values a diversified healthcare company. Its market capitalization combines cell therapy developments and medical network management. This complex diagram illustrates how the market is attempting to value a hybrid biotech-services model.
Book value capitalization of the company, segment and market as a whole
ALBT - Book value capitalization of the company Avalon GloboCare
Avalon GloboCare, a cell therapy company, derives its book value from its physical foundation: laboratories, clinical centers, and technology rights. The chart below shows how the company built this physical and scientific foundation for its innovative treatments.
ALBT - Share of the company's book capitalization Avalon GloboCare within the market segment - Treatment
Avalon GloboCare Corp. is a cell therapy company. Its core assets are a network of affiliated clinics, laboratories, and R&D centers that form a vertically integrated ecosystem for regenerative medicine. The chart shows the company's control over this unique medical infrastructure.
Market segment balance sheet capitalization - Treatment
Avalon GloboCare is a cell therapy company. The pharmaceutical industry, as the chart shows, is capital-intensive. Avalon is a prime example. Its business requires the construction of its own highly complex and expensive laboratories and factories.
Book value of all companies included in the broad market index - GURU.Markets
Avalon GloboCare's assets are not clinics, but a diversified portfolio that includes cell therapy development (CAR-T), consulting services, and medical center management. The book value reflects the combined weight of these diverse healthcare assets.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Avalon GloboCare
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its market capitalization is a measure of its scientific portfolio and ecosystem. The chart below shows how the market views its diversified and complex strategy.
Market to book capitalization ratio in a market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its value is based on its scientific programs and technology platforms. The chart shows how investors value its development pipeline.
Market to book capitalization ratio for the market as a whole
Avalon GloboCare operates in the cell therapy field. Its market valuation is a bet on the success of its scientific developments and partnerships. This chart illustrates the typical biotech gap between book value and market capitalization based on future potential.
Debts of the company, segment and market as a whole
ALBT - Company debts Avalon GloboCare
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Developing such complex and personalized treatments requires massive investments in R&D and clinical trials. This chart shows how the company raises capital to fund its cutting-edge, yet highly expensive, research programs.
Market segment debts - Treatment
Avalon GloboCare is a biotech company focused on cell therapy. Its financial structure is typical for early-stage biotech companies: no revenue and reliance on equity to fund R&D. This chart shows its cash reserves.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Avalon GloboCare
Avalon GloboCare is a biotech company working in cell therapy. This chart shows its financial structure. As with most development-stage companies in this field, debt is a huge risk. Financing must come from equity.
Market segment debt to market segment book capitalization - Treatment
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine, one of the most advanced and capital-intensive fields of science. The chart shows the overall debt burden in the sector, highlighting the enormous financial resources the company requires to advance its innovative developments.
Debt to book value of all companies in the market
Avalon GloboCare Corp. operates in cell therapy and regenerative medicine, a cutting-edge but risky field. This chart, reflecting the debt of an established economy, emphasizes that Avalon's funding is a venture bet on the future of medicine, entirely dependent on research results and investor support, not debt.
P/E of the company, segment and market as a whole
P/E - Avalon GloboCare
This chart for Avalon GloboCare, a cell therapy and regenerative medicine company, shows a speculative valuation. P/E ratios are not applicable here. This reflects investors' faith in its scientific research and its consulting business, which helps other biotech companies.
P/E of the market segment - Treatment
Avalon GloboCare is a biotechnology company that develops and delivers solutions in cell therapy and regenerative medicine. This chart shows the average valuation for the sector, providing investors with context for evaluating Avalon's portfolio and strategy.
P/E of the market as a whole
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its valuation is a pure bet on the success of its scientific developments. It is in no way tied to the general economic cycles illustrated by this chart. Its fate is decided in clinics and the minds of regulators, not on the stock market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Avalon GloboCare
Avalon GloboCare is a biotechnology company focused on cell therapies, including CAR-T and other regenerative medicine approaches. This chart reflects investor expectations for its clinical programs and technology platform. The valuation is based on the long-term potential of its cell engineering developments.
%20P%2FE%20Avalon%20GloboCare&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Avalon-GloboCare&v=1772641713502 "Chart of the company's future (projected) P/E Avalon GloboCare")
Future (projected) P/E of the market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its valuation relative to other biotechs reflects investor sentiment on its diversified approach, which includes technology development and services. This reflects how the market views its complex business model.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Treatment&v=1772641713503 "Future (projected) P/E graph of the market segment - Treatment")
Future (projected) P/E of the market as a whole
Avalon GloboCare is a biotech company focused on cell therapy, including CAR-T technology, and regenerative medicine. Its business is at the cutting edge of science. This chart shows the overall risk appetite of investors. For companies operating in such breakthrough fields, a positive market environment is critical to attracting significant investment.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641713513 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Avalon GloboCare
Avalon GloboCare is a biotechnology company focused on cell therapy (including CAR-T) and regenerative medicine. The financial performance shown here reflects its investments in developing cutting-edge medical technologies and building an ecosystem for their application.
Profit of companies in the market segment - Treatment
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. This chart shows the overall profitability of the healthcare and biotechnology sectors. It helps assess how far these advanced treatments have progressed from the research stage to the development of commercially successful products.
Overall market profit
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. Its future depends on the success of its technology development and commercialization. The macroeconomic cycles visible in this chart are secondary to scientific and regulatory milestones for ALBT.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Avalon GloboCare
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. Its future revenue forecast depends on the success of its clinical programs and partnerships. This chart reflects analyst expectations for its developments and their potential to treat various diseases.
%20profit%20of%20the%20company%20Avalon%20GloboCare&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Avalon-GloboCare&v=1772641713599 "Graph of future (projected) profit of the company Avalon GloboCare")
Future (predicted) profit of companies in the market segment - Treatment
Avalon GloboCare is a biotech company developing a portfolio of cell therapy technologies, including CAR-T, and providing healthcare consulting services. This chart shows forecasts for the healthcare services sector. It illustrates how hybrid models combining R&D and service are struggling to find their place in the complex healthcare ecosystem.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Treatment&v=1772641713600 "Graph of future (predicted) profits of companies in a market segment - Treatment")
Future (predicted) profit of the market as a whole
For Avalon GloboCare, a company focused on cell therapy and regenerative medicine, this schedule is important for the investment climate. Economic growth and investor appetite for risk are facilitating the capital needed to develop and commercialize cutting-edge medical technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641713600 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Avalon GloboCare
Avalon GloboCare is a biotechnology company specializing in cell therapy and regenerative medicine. This metric reflects investors' assessment of its scientific potential and future revenue, not current sales.
P/S market segment - Treatment
Avalon GloboCare is a biotechnology company focused on cell therapy, including CAR-T technology, and regenerative medicine services. This chart shows the average valuation for the healthcare services sector. It reflects investor confidence in the potential of advanced cell technologies for treating cancer and other diseases.
P/S of the market as a whole
Avalon GloboCare Corp. is a biotech company focused on cell therapy, including CAR-T technologies, and also provides healthcare consulting services. Its valuation is a blend of current consulting revenue and future biotech potential. This chart helps evaluate this hybrid business model.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Avalon GloboCare
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its valuation is based on the future potential of its developments. The chart demonstrates investors' confidence in its scientific platform and ability to develop innovative treatments.
%20P%2FS%20Avalon%20GloboCare&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Avalon-GloboCare&v=1772641713651 "The graph of the company's future (projected) P/S Avalon GloboCare")
Future (projected) P/S of the market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy (including CAR-T) and regenerative medicine. It also provides healthcare consulting services. This chart shows how investors view its diversified model, which combines biotech development and services.
%20P%2FS%20market%20segment%20graph%20-%20Treatment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Treatment&v=1772641713671 "Future (projected) P/S market segment graph - Treatment")
Future (projected) P/S of the market as a whole
This chart reflects expectations for the cell therapy sector. For Avalon GloboCare, a company developing and commercializing regenerative medicine technologies, this is a sign of faith in the future. Market optimism allows for funding breakthrough treatments that could change the way we fight serious diseases.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641713710 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Avalon GloboCare
Avalon GloboCare is a biotechnology company developing and providing cell therapy services, including CAR-T. This chart shows revenue from consulting services and subsidiaries working in regenerative medicine. Growth will depend on the commercialization of its cell technologies.
Sales of companies in the market segment - Treatment
Avalon GloboCare is a biotech company specializing in cell therapies, including CAR-T and exosomes. This chart shows its growth in the healthcare services and development sector. Avalon is at the forefront of regenerative medicine, developing platforms that could lead to breakthrough treatments for cancer and other diseases.
Overall market sales
Avalon GloboCare Corp. operates in cell therapy and regenerative medicine. Its success depends on scientific development and technology commercialization. The overall economic situation, shown in this chart, influences the investment climate in the biotech sector and the availability of funding for cutting-edge medical research.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Avalon GloboCare
Avalon GloboCare is a biotechnology company focused on cell therapy, including CAR-T technologies, and healthcare consulting services. This chart reflects aggregate analyst expectations across all areas of the company's operations, from research to consulting.
%20sales%20of%20the%20company%20Avalon%20GloboCare&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Avalon-GloboCare&v=1772641713773 "Schedule of future (projected) sales of the company Avalon GloboCare")
Future (projected) sales of companies in the market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. This chart reflects expectations for the entire healthcare sector. It reflects the significant potential and interest in advanced treatments such as CAR-T therapy, where Avalon is seeking to carve out a niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Treatment&v=1772641713794 "Schedule of future (projected) sales of companies in the market segment - Treatment")
Future (projected) sales of the market as a whole
Avalon GloboCare Corp. is a biotechnology company focused on cell therapy, including CAR-T and exosome technologies. Its success depends on progress in clinical development and partnerships. The overall economic situation, reflected in this chart, impacts the availability of capital for funding advanced and capital-intensive areas of medicine, such as cell therapy.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641713810 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Avalon GloboCare
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. This chart shows its financial performance during the research and development phase. Negative values reflect investments in developing a portfolio of advanced therapeutic and diagnostic technologies.
Market segment marginality - Treatment
Avalon GloboCare is a biotechnology company developing cell therapy and providing healthcare services. Its profitability depends on the success of both its scientific developments and commercial services. This chart, showing the average profitability in the sector, helps assess the potential of both businesses and their synergies.
Market marginality as a whole
Avalon GloboCare is a biotechnology company specializing in cell therapy and regenerative medicine. This overall market profitability chart is irrelevant to the company. Its potential lies in its scientific developments and ability to create innovative treatments. Success depends on clinical trial data, not the state of the economy.
Employees in the company, segment and market as a whole
Number of employees in the company Avalon GloboCare
Avalon GloboCare is a biotech company focused on cell therapy, including CAR-T-related technologies. This graphic shows a small team of scientists and managers advancing their innovative developments through partnerships and clinical trials.
Share of the company's employees Avalon GloboCare within the market segment - Treatment
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. This chart shows the percentage of leading scientists and clinicians in this cutting-edge field that Avalon attracts. It reflects its concentration of intellectual capital necessary for the development and commercialization of breakthrough medical technologies.
Number of employees in the market segment - Treatment
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. This graph shows how complex "living" drugs are created at the cutting edge of science, requiring an army of scientists, doctors, and highly skilled technicians in sterile laboratories for their production and use.
Number of employees in the market as a whole
Avalon GloboCare works in cell therapy and regenerative medicine, one of the most advanced and capital-intensive fields of science. This graph reflects the entire economy, but its future is determined specifically by R&D centers like these. Avalon is contributing to the creation of a unique talent pool that will shape medicine in the coming decades.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Avalon GloboCare (ALBT)
Avalon GloboCare is a biotechnology company specializing in cell therapy and regenerative medicine. This chart is a classic example of intellectual capital valuation. The company's value is based on market expectations for its scientific platform and development pipeline. The chart shows how highly the market values this scientific potential per scientist.
%20of%20the%20company%20Avalon%20GloboCare%20(ALBT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Avalon-GloboCare-ALBT&v=1772641714017 "Chart of market capitalization per employee (in thousands of dollars) of the company Avalon GloboCare (ALBT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy and regenerative medicine. Its value is determined by the potential of its scientific platform. The chart shows investors' bets on its research team, reflecting expectations for the future of cell technologies.
%20by%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Treatment&v=1772641714019 "Market capitalization per employee (in thousands of dollars) by market segment - Treatment")
Market capitalization per employee (in thousands of dollars) for the overall market
Avalon GloboCare Corp. is a biotechnology company focused on cell therapy and regenerative medicine. This chart shows the overall market productivity metric, highlighting the high cost of scientific innovation.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641714037 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Avalon GloboCare (ALBT)
Avalon GloboCare is a biotech company focused on cell therapy. They operate at the intersection of R&D and service delivery. This chart shows how the company balances R&D losses with potential revenue from its clinical services, per employee.
%20Chart%20Avalon%20GloboCare%20(ALBT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Avalon-GloboCare-ALBT&v=1772641714040 "Company Profit Per Employee (in thousands of dollars) Chart Avalon GloboCare (ALBT)")
Profit per employee (in thousands of dollars) in the market segment - Treatment
Avalon GloboCare Corp. is a biotech company specializing in cell therapy and regenerative medicine. Its core business is research and development. The negative earnings per employee (EPE), which this chart likely shows, is typical for biotech companies in clinical trials and reflects the high investment in their research team.
%20in%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Treatment&v=1772641714050 "Chart of profit per employee (in thousands of dollars) in the market segment - Treatment")
Profit per employee (in thousands of dollars) for the market as a whole
Avalon GloboCare (ALBT) is a biotechnology company developing cell therapies (CAR-T, CAR-NK) and providing services (laboratory, consulting) for the life sciences sector. It is a hybrid of R&D and B2B services. This chart shows the market average dollar return per employee. It helps assess how effectively ALBT utilizes its staff across these two distinct segments.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641714051 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Avalon GloboCare (ALBT)
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. This chart is a predictor of the future, reflecting the potential for successful clinical trials to lead to commercialization of the therapy and significant revenue growth.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Avalon-GloboCare-ALBT&v=1772641714061 "Sales chart per company employee Avalon GloboCare (ALBT)")
Sales per employee in the market segment - Treatment
Avalon GloboCare is a biotechnology company focused on cell therapy and regenerative medicine. The company is in the R&D stage. This chart shows the average revenue per employee in this segment. It serves as a productivity benchmark for commercial pharmaceutical companies and helps evaluate the effectiveness of Avalon's scientific team.
Sales per employee for the market as a whole
Avalon GloboCare is a biotech company focused on cell therapy (CAR-T) and diagnostics. The company has no stable commercial revenue; its business consists of R&D and clinical center management. This metric is irrelevant, as value is created in the laboratory, not through sales.
Short shares by company, segment and market as a whole
Shares shorted by company Avalon GloboCare (ALBT)
Avalon GloboCare is a biotech company exploring cell therapy (CAR-T) and regenerative medicine. The company has a complex structure and Chinese roots. This chart highlights the bets that it's an opaque structure with no real science. Bears are doubting their developments and financial statements.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Avalon-GloboCare-ALBT&v=1772641714112 "Short Shares Chart for the Company Avalon GloboCare (ALBT)")
Shares shorted by market segment - Treatment
Avalon GloboCare Corp. is a biotech company focused on cell therapy (including CAR-T) and regenerative medicine services. This chart reflects the total short position in the cell therapy sector. High values indicate general investor skepticism about the safety, efficacy, or commercialization of these complex treatments.
Shares shorted by the overall market
Avalon GloboCare is a biotech holding company focused on cell therapy and regenerative medicine. This chart illustrates the overall market pessimism. When fear is king, investors avoid complex holding structures and speculative biotechs. ALBT combines both of these factors, leading investors to sell off the stock, fearing risks in both R&D and the company's structure.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Avalon GloboCare (ALBT)
Avalon GloboCare is a biotech company working in cell therapy (CAR-T) and regenerative medicine. It's at the cutting edge of science. This oscillator measures hype, showing overbought peaks (above 70) at announcements and deep oversold troughs (below 30) pending FDA approval.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Avalon-GloboCare-ALBT&v=1772641714139 "RSI 14 indicator chart for the company's stock Avalon GloboCare (ALBT)")
RSI 14 Market Segment - Treatment
Avalon GloboCare is a biotech company focused on developing cell therapy (CAR-T) and providing services for the healthcare sector (including clinical management). This chart measures the collective excitement in the cell therapy sector. It helps determine whether the entire speculative segment is overheated.
RSI 14 for the overall market
For Avalon GloboCare, a biotech in R&D, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is turned off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ALBT (Avalon GloboCare)
Avalon GloboCare is a biotech company focused on cell therapy (CAR-T) and diagnostic solutions. This chart shows the average target price. Analysts' forecasts are based on the progress of its clinical therapeutic programs and the commercialization of its diagnostic and laboratory services.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ALBT-Avalon-GloboCare&v=1772641714177 "A chart showing analyst consensus forecasts for the expected stock price. ALBT (Avalon GloboCare)")
The difference between the consensus estimate and the actual stock price ALBT (Avalon GloboCare)
Avalon GloboCare is a biotech company building an ecosystem for cell therapy (CAR-T), including proprietary drug development and services. This chart shows the difference between the market valuation and the consensus estimate. It reveals whether experts believe in their R&D portfolio and hybrid business model.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ALBT-Avalon-GloboCare&v=1772641714217 "A chart showing the difference between the consensus forecast and the actual stock price. ALBT (Avalon GloboCare)")
Analyst consensus forecast for stock prices by market segment - Treatment
Avalon GloboCare is a biotech company focused on cell therapy (CAR-T) and regenerative medicine. This chart shows analysts' overall expectations for the treatment sector. It reflects whether experts believe in a breakthrough in cell technologies or consider the sector too risky.
Analysts' consensus forecast for the overall market share price
Avalon GloboCare (ALBT) is a biomedical holding company. They do a little bit of everything: from cell therapy and R&D to managing medical centers. It's a complex and speculative structure. This chart shows the overall risk appetite. It reflects how willing investors are to invest in complex, opaque, and unprofitable biotech holdings.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Avalon GloboCare
Avalon GloboCare is a cell therapy incubator. They're not just R&D; they're trying to build an ecosystem: they're developing their R&D pipelines (CAR-T) and also providing services (laboratories, consulting) to other biotechs. This chart is a summary indicator of their hybrid model. It weighs their speculative R&D against their (still) small service business.
AKIMA Market Segment Index - Treatment
Avalon GloboCare (ALBT) is a diversified biotech company. Their portfolio spans cell therapy development (CAR-T), diagnostics, and healthcare management. This chart shows the segment's average index, helping investors assess how their portfolio's approach to healthcare compares to the sector average.
The AKIM Index for the overall market
Avalon GloboCare is a holding company focused on cell technologies and laboratory diagnostics. This chart, which reflects the market average, provides a macro backdrop. It helps assess how ALBT, a diversified microcap company in healthcare, compares to overall economic trends.
